SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-118497
Filing Date
2024-10-30
Accepted
2024-10-29 21:27:36
Documents
18
Period of Report
2024-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20241029.htm   iXBRL 8-K 50599
2 EX-1.1 eldn-ex1_1.htm EX-1.1 451503
3 EX-4.1 eldn-ex4_1.htm EX-4.1 127899
4 EX-5.1 eldn-ex5_1.htm EX-5.1 28418
5 EX-99.1 eldn-ex99_1.htm EX-99.1 13058
6 GRAPHIC img20068692_0.jpg GRAPHIC 7613
7 GRAPHIC img24513963_0.jpg GRAPHIC 18129
8 GRAPHIC img24513963_1.jpg GRAPHIC 18129
  Complete submission text file 0000950170-24-118497.txt   956749

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20241029.xsd EX-101.SCH 24852
20 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20241029_htm.xml XML 4703
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 241407163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)